Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 1, 2026
Accession Number:
0001104659-26-038081
Submission Type:
POS AM
CIK:
0001129928
Company Name:
ONCOLYTICS BIOTECH INC
File Number:
333-289819